Cheuk Ka Tong

Cheuk Ka Tong is currently the Director of Strategy and External Collaborations at Tikva Allocell Pte Ltd. Prior to this role, Cheuk Ka Tong worked at Tessa Therapeutics Ltd as an Associate Director, primarily focusing on program management in the CSO Office. Cheuk Ka Tong was also involved in various roles at the Genome Institute of Singapore, including Chief Operating Officer at POLARIS, where they successfully obtained FDA approval for an analytical assay. With a background in neuroscience and biochemistry, Cheuk Ka Tong has a strong research foundation, having worked on projects related to immunotherapies, stem cell biology, and neural cell-based therapies.